423
Views
0
CrossRef citations to date
0
Altmetric
Review

Translational Role of Natural Coumarins and Their Derivatives As Anticancer Agents

&
Pages 1057-1082 | Received 02 Aug 2018, Accepted 24 Jan 2019, Published online: 29 May 2019

References

  • Lim GB . Warfarin: from rat poison to clinical use. Nat. Rev. Cardiol.doi: 10.1038/nrcardio.2017.172 (2017).
  • Kusuma BR , KhandelwalA , GuWet al. Synthesis and biological evaluation of coumarin replacements of novobiocin as Hsp90 inhibitors. Biorg. Med. Chem.22(4), 1441–1449 (2014).
  • Hall JA , SeedaralaS , ZhaoH , GargG , GhoshS , BlaggBSJ. Novobiocin analogues that inhibit the MAPK pathway. J. Med. Chem.59(3), 925–933 (2016).
  • Cary DC , PeterlinBM. Natural products and HIV/AIDS. AIDS Res. Hum. Retroviruses34(1), 31–38 (2018).
  • Hassan MZ , OsmanH , AliMA , AhsanMJ. Therapeutic potential of coumarins as antiviral agents. Eur. J. Med. Chem.123, 236–255 (2016).
  • Petersen M , HansJ , MaternU. Biosynthesis of phenylpropanoids and related compounds. Annual Plant Reviews Volume 40: Biochemistry of Plant Secondary Metabolism.WinkM ( Ed.). Blackwell Publishing Ltd, Singapore, 182–257 (2010).
  • Dewick PM . The acetate pathway: fatty acids and polyketides. Medicinal Natural Products.DewickPM ( Ed.). John Wiley & Sons, Ltd,Chichester, West Sussex, UK (2009).
  • Menezes JC , OrlikovaB , MorceauF , DiederichM. Natural and synthetic flavonoids: structure–activity relationship and chemotherapeutic potential for the treatment of leukemia. Crit. Rev. Food Sci. Nutr.56(Supp. 1), S4–S28 (2016).
  • Menezes JC , EdrakiN , KamatSPet al. Long chain alkyl esters of hydroxycinnamic acids as promising anticancer agents: selective induction of apoptosis in cancer cells. J. Agric. Food Chem.65(33), 7228–7239 (2017).
  • Pinto DC , SilvaAMS. Anticancer natural coumarins as lead compounds for the discovery of new drugs. Curr. Top. Med. Chem.17(29), 3190–3198 (2017).
  • Filipsky T , RihaM , MacakovaK , AnzenbacherováE , KarlickovaJ , MladenkaP. Antioxidant effects of coumarins include direct radical scavenging, metal chelation and inhibition of ROS-producing enzymes. Curr. Top. Med. Chem.15(5), 415–431 (2015).
  • Sarker SD , NaharL. Progress in the chemistry of naturally occurring coumarins. Progress in the Chemistry of Organic Natural Products.KinghornAD, FalkH, GibbonsS, KobayashiJi ( Eds). Springer International Publishing, Cham, Switzerland, 241–304 (2017).
  • Stefanachi A , LeonettiF , PisaniL , CattoM , CarottiA. Coumarin: a natural, privileged and versatile scaffold for bioactive compounds. Molecules23(2), 250 (2018).
  • Detsi A , KontogiorgisC , Hadjipavlou-LitinaD. Coumarin derivatives: an updated patent review (2015–2016). Expert Opin. Ther. Pat.27(11), 1201–1226 (2017).
  • Costa M , DiasTA , BritoA , ProençaF. Biological importance of structurally diversified chromenes. Eur. J. Med. Chem.123, 487–507 (2016).
  • Cancer Research UK (2018). www.cancerresearchuk.org/health-professional/cancer-statistics/worldwide-cancer
  • Nakano D , IshitsukaK , MatsudaNet al. Screening of promising chemotherapeutic candidates from plants against human adult T-cell leukemia/lymphoma (V): coumarins and alkaloids from Boenninghausenia japonica and Ruta graveolens. J. Nat. Med.71(1), 170–180 (2017).
  • Mager DL . Bacteria and cancer: cause, coincidence or cure? A review. J. Transl. Med.4, 14 (2006).
  • de Martel C , FerlayJ , FranceschiSet al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol.13(6), 607–615 (2012).
  • Bisacchi GS , HaleMR. A ‘double-edged’ scaffold: antitumor power within the antibacterial quinolone. Curr. Med. Chem.23(6), 520–577 (2016).
  • Brown AS , PatelCJ. A standard database for drug repositioning. Sci. Data4, 170029 (2017).
  • Bullman S , PedamalluCS , SicinskaEet al. Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer. Science358(6369), 1443–1448 (2017).
  • Arora R , SawneyS , SalujaD. Potential therapeutic approaches for the treatment of acute myeloid leukemia with AML1-ETO translocation. Curr. Cancer Drug Targets16(3), 215–225 (2016).
  • Rubio V , CalviñoE , García-PérezA , HerráezA , DiezJC. Human acute promyelocytic leukemia NB4 cells are sensitive to esculetin through induction of an apoptotic mechanism. Chem.-Biol. Interact.220, 129–139 (2014).
  • Taniguchi K , FunasakiM , KishidaAet al. Two new coumarins and a new xanthone from the leaves of Rhizophora mucronata. Bioorg. Med. Chem. Lett.28(6), 1063–1066 (2018).
  • Tung NH , UtoT , SakamotoAet al. Antiproliferative and apoptotic effects of compounds from the flower of Mammea siamensis (Miq.) T. Anders. on human cancer cell lines. Bioorg. Med. Chem. Lett.23(1), 158–162 (2013).
  • Uto T , TungN , ThongjankaewP , LhieochaiphantS , ShoyamaY. Kayeassamin a isolated from the flower of Mammea siamensis triggers apoptosis by activating caspase-3/-8 in HL-60 human leukemia cells. Pharmacognosy Res.8(4), 244–248 (2016).
  • Farley CM , DibweDF , UedaJ-y , HallEA , AwaleS , MagolanJ. Evaluation of synthetic coumarins for antiausterity cytotoxicity against pancreatic cancers. Bioorg. Med. Chem. Lett.26(5), 1471–1474 (2016).
  • Tanabe G , TsutsuiN , ShibataniKet al. Total syntheses of the aromatase inhibitors, mammeasins C and D, from Thai medicinal plant Mammea siamensis. Tetrahedron73(30), 4481–4486 (2017).
  • Wang K-W , LiD , WuB , CaoX-J. New cytotoxic dimeric and trimeric coumarins from Chimonanthus salicifolius. Phytochem. Lett.16, 115–120 (2016).
  • Li W , SunYN , YanXTet al. Coumarins and lignans from Zanthoxylum schinifolium and their anticancer activities. J. Agric. Food Chem.61(45), 10730–10740 (2013).
  • Kubrak T , Bogucka-KockaA , KomstaŁet al. Modulation of multidrug resistance gene expression by coumarin derivatives in human leukemic cells. Oxid. Med. Cell. Longev.2017, 13 (2017).
  • Jakubowski R , PomorskaDK , DługoszAet al. Synthesis of 4,4-disubstituted 3-methylidenechroman-2-ones as potent anticancer agents. ChemMedChem12(8), 599–605 (2017).
  • Liu C-F , ShenQ-K , LiJ-J , TianY-S , QuanZ. Synthesis and biological evaluation of novel 7-hydroxy-4-phenylchromen-2-one–linked to triazole moieties as potent cytotoxic agents. J. Enzyme Inhib. Med. Chem.32(1), 1111–1119 (2017).
  • Xu H , LaraiaL , SchneiderLet al. Highly enantioselective catalytic vinylogous propargylation of coumarins yields a class of autophagy inhibitors. Angew. Chem. Int. Ed.56(37), 11232–11236 (2017).
  • Dong L , XuW , LiH , BiK. In vitro and in vivo anticancer effects of marmesin in U937 human leukemia cells are mediated via mitochondrial-mediated apoptosis, cell cycle arrest, and inhibition of cancer cell migration. Oncol. Rep.39, 597–602 (2018).
  • Lei L , XueY-b , LiuZet al. Coumarin derivatives from Ainsliaea fragrans and their anticoagulant activity. Sci. Rep.5, 13544 (2015).
  • Ban H , UchakinaO , McKallipRJ. Hyaluronic acid inhibitor 4-methylumbelliferone activates the intrinsic apoptosis pathway in K562 chronic myelogenous leukemia cells. Anticancer Res.35(10), 5231–5240 (2015).
  • Lompardía SL , DíazM , PapademetrioDL , PibuelM , ÁlvarezÉ , HajosSE. 4-methylumbelliferone and imatinib combination enhances senescence induction in chronic myeloid leukemia cell lines. Invest. New Drugs35(1), 1–10 (2017).
  • Rungrojsakul M , KatekunlaphanT , SaiaiAet al. Down-regulatory mechanism of mammea E/BB from Mammea siamensis seed extract on Wilms’ tumor 1 expression in K562 cells. BMC Complementary Altern. Med.16(1), 130 (2016).
  • Jin L , TabeY , KimuraSet al. Antiproliferative and proapoptotic activity of GUT-70 mediated through potent inhibition of Hsp90 in mantle cell lymphoma. Br. J. Cancer104, 91–100 (2011).
  • Matsuda K , HattoriS , KariyaRet al. Inhibition of HIV-1 entry by the tricyclic coumarin GUT-70 through the modification of membrane fluidity. Biochem. Biophys. Res. Commun.457(3), 288–294 (2015).
  • Wang S-Q , LiX , WangX-N , WeiN-N , LouH-X. Coumarins from Cicuta virosa and their modulating effects on multidrug-resistant (MDR) tumors. Phytochem. Lett.4(2), 97–100 (2011).
  • Abdallah HM , Al-AbdAM , El-DineRS , El-HalawanyAM. P-glycoprotein inhibitors of natural origin as potential tumor chemo-sensitizers: a review. J. Adv. Res.6(1), 45–62 (2015).
  • Sakunpak A , MatsunamiK , OtsukaH , PanichayupakaranantP. Isolation of new monoterpene coumarins from Micromelum minutum leaves and their cytotoxic activity against Leishmania major and cancer cells. Food Chem.139(1), 458–463 (2013).
  • Pavlović I , PetrovićS , MilenkovićMet al. Antimicrobial and cytotoxic activity of extracts of Ferula heuffelii Griseb. ex Heuff. and its metabolites. Chem. Biodivers.12(10), 1585–1594 (2015).
  • Zhang L , TongX , ZhangJ , HuangJ , WangJ. DAW22, a natural sesquiterpene coumarin isolated from Ferula ferulaeoides (Steud.) Korov. that induces C6 glioma cell apoptosis and endoplasmic reticulum (ER) stress. Fitoterapia103, 46–54 (2015).
  • Julien O , KampmannM , BassikMCet al. Unraveling the mechanism of cell death induced by chemical fibrils. Nat. Chem. Biol.10, 969 (2014).
  • Zhou J , XuB. Enzyme-instructed self-assembly: a multistep process for potential cancer therapy. Bioconjug. Chem.26(6), 987–999 (2015).
  • Kadia TM , RavandiF , CortesJ , KantarjianH. New drugs in acute myeloid leukemia. Ann. Oncol.27(5), 770–778 (2016).
  • Kozako T , SoedaS , YoshimitsuMet al. Angiotensin II type 1 receptor blocker telmisartan induces apoptosis and autophagy in adult T-cell leukemia cells. FEBS Open Bio.6(5), 442–460 (2016).
  • Wang Y , LiuH , LuPet al. Design, synthesis, and in vitro evaluation of novel 3, 7-disubstituted coumarin derivatives as potent anticancer agents. Chem. Biol. Drug Des.86(4), 637–647 (2015).
  • Paul K , BindalS , LuxamiV. Synthesis of new conjugated coumarin–benzimidazole hybrids and their anticancer activity. Bioorg. Med. Chem. Lett.23(12), 3667–3672 (2013).
  • Tsay S-C , HwuJR , SinghaRet al. Coumarins hinged directly on benzimidazoles and their ribofuranosides to inhibit hepatitis C virus. Eur. J. Med. Chem.63, 290–298 (2013).
  • Singh LR , AvulaSR , RajSet al. Coumarin–benzimidazole hybrids as a potent antimicrobial agent: synthesis and biological elevation. J. Antibiot. (Tokyo)70, 954 (2017).
  • Bistrovic A , StipanicevN , Opacak-BernardiTet al. Synthesis of 4-aryl-1,2,3-triazolyl appended natural coumarin-related compounds with antiproliferative and radical scavenging activities and intracellular ROS production modification. New J. Chem.41(15), 7531–7543 (2017).
  • Xi G-L , LiuZ-Q. Coumarin-fused coumarin: antioxidant story from N, N-dimethylamino and hydroxyl groups. J. Agric. Food Chem.63(13), 3516–3523 (2015).
  • El-Gamal MI , OhC-H. Synthesis, in vitro antiproliferative activity, and in silico studies of fused tricyclic coumarin sulfonate derivatives. Eur. J. Med. Chem.84, 68–76 (2014).
  • Parcha P , SarvagallaS , MadhuriBet al. Identification of natural inhibitors of BCR-ABL for the treatment of chronic myeloid leukemia. Chem. Biol. Drug Des.90(4), 596–608 (2017).
  • Chen H , GaoS , LiJet al. Wedelolactone disrupts the interaction of EZH2-EED complex and inhibits PRC2-dependent cancer. Oncotarget6(15), 13049–13059 (2015).
  • Chen Z , SunX , ShenSet al. Wedelolactone, a naturally occurring coumestan, enhances interferon-γ signaling through inhibiting STAT1 protein dephosphorylation. J. Biol. Chem.288(20), 14417–14427 (2013).
  • Wiemer AJ , ShippyRR , KilcollinsAMet al. Evaluation of a 7-methoxycoumarin-3-carboxylic acid ester derivative as a fluorescent, cell-cleavable, phosphonate protecting group. ChemBioChem17(1), 52–55 (2016).
  • Molaverdi F , KhoobiM , EmamiSet al. Polyoxygenated cinnamoylcoumarins as conformationally constrained analogs of cytotoxic diarylpentanoids: synthesis and biological activity. Eur. J. Med. Chem.68, 103–110 (2013).
  • Elshemy HAH , ZakiMA. Design and synthesis of new coumarin hybrids and insight into their mode of antiproliferative action. Biorg. Med. Chem.25(3), 1066–1075 (2017).
  • Ashraf R , Hamidullah , HasanainMet al. Coumarin–chalcone hybrid instigates DNA damage by minor groove binding and stabilizes p53 through post translational modifications. Sci. Rep.7, 45287 (2017).
  • Tan G , YaoY , GuYet al. Cytotoxicity and DNA binding property of the dimers of triphenylethylene–coumarin hybrid with one amino side chain. Bioorg. Med. Chem. Lett.24(13), 2825–2830 (2014).
  • Lee J-Y , MazumderA , DiederichM. Preclinical assessment of the bioactivity of the anticancer coumarin OT48 by spheroids, colony formation assays, and zebrafish xenografts. JoVE (136), e57490 (2018).
  • Lee J-Y , TalhiO , JangDet al. Cytostatic hydroxycoumarin OT52 induces ER/Golgi stress and STAT3 inhibition triggering non-canonical cell death and synergy with BH3 mimetics in lung cancer. Cancer Lett.416, 94–108 (2018).
  • Mazumder A , LeeJ-Y , TalhiOet al. Hydroxycoumarin OT-55 kills CML cells alone or in synergy with imatinib or synribo: involvement of ER stress and DAMP release. Cancer Lett.438, 197–218 (2018).
  • Jeong SY , NguyenPH , ZhaoBT , MinBS , MaES , WooMH. Bioactive constituents from the leaves of Zanthoxylum schinifolium. Nat. Prod. Sci.21(1), 1–5 (2015).
  • Suauam P , YingyongnarongkulB-E , PalagaT , MiyakawaT , YompakdeeC. Clausmarin A, potential immunosuppressant revealed by yeast-based assay and interleukin-2 production assay in Jurkat T cells. PLoS ONE10(8), e0136804 (2015).
  • Leanza L , RomioM , BeckerKAet al. Direct pharmacological targeting of a mitochondrial ion channel selectively kills tumor cells in vivo. Cancer Cell31(4), 516–531 (2017).
  • Sikka S , ShanmugamMK , KannaiyanRet al. Suppression of essential pro-inflammatory signaling pathways by natural agents for the therapy of multiple myeloma. Phytochem. Rev.13(1), 79–106 (2014).
  • Jang J , JeongS-J , KwonH-Yet al. Decursin and doxorubicin are in synergy for the induction of apoptosis via STAT3 and/or mTOR pathways in human multiple myeloma cells. Evid. Based Complement. Alternat. Med.2013, 13 (2013).
  • Choi Pj , OY , HerJ-H , YunE , SongGY , OhS. Anti-proliferative activity of CGK012 against multiple myeloma cells via Wnt/β-catenin signaling attenuation. Leuk. Res.60, 103–108 (2017).
  • Losson H , SchnekenburgerM , DicatoM , DiederichM. Natural compound histone deacetylase inhibitors (HDACi): synergy with inflammatory signaling pathway modulators and clinical applications in cancer. Molecules21(11), 1608 (2016).
  • Seidel C , SchnekenburgerM , ZwergelCet al. Novel inhibitors of human histone deacetylases: design, synthesis and bioactivity of 3-alkenoylcoumarines. Bioorg. Med. Chem. Lett.24(16), 3797–3801 (2014).
  • Abdizadeh T , KalaniMR , AbnousKet al. Design, synthesis and biological evaluation of novel coumarin-based benzamides as potent histone deacetylase inhibitors and anticancer agents. Eur. J. Med. Chem.132, 42–62 (2017).
  • Lee JT , GuW. SIR T1: regulator of p53 deacetylation. Genes Cancer4(3-4), 112–117 (2013).
  • Kumar A , ChauhanS. How much successful are the medicinal chemists in modulation of SIRT1: a critical review. Eur. J. Med. Chem.119, 45–69 (2016).
  • Mboge M , MahonB , McKennaR , FrostS. Carbonic anhydrases: role in pH control and cancer. Metabolites8(1), 19 (2018).
  • Iessi E , LogozziM , MizzoniD , DiRaimo R , SupuranC , FaisS. Rethinking the combination of proton exchanger inhibitors in cancer therapy. Metabolites8(1), 2 (2018).
  • Davis RA , VulloD , MarescaA , SupuranCT , PoulsenS-A. Natural product coumarins that inhibit human carbonic anhydrases. Biorg. Med. Chem.21(6), 1539–1543 (2013).
  • Imbert V , NeboutM , MaryDet al. Co-targeting intracellular pH and essential amino acid uptake cooperates to induce cell death of T-ALL/LL cells. Leuk. Lymphoma59(2), 460–468 (2018).
  • Bozdag M , AlafeefyAM , AltamimiAM , VulloD , CartaF , SupuranCT. Coumarins and other fused bicyclic heterocycles with selective tumor-associated carbonic anhydrase isoforms inhibitory activity. Biorg. Med. Chem.25(2), 677–683 (2017).
  • Sharp S , JonesK , WorkmanP. Chapter 9 – exploiting cancer dependence on molecular chaperones: HSP90 inhibitors past, present, and future. Cancer Drug Design and Discovery (2nd Edition).NeidleS ( Ed.). Academic Press, CA, USA, 239–274 (2014).
  • Pendleton M , LindseyRH , FelixCA , GrimwadeD , OsheroffN. Topoisomerase II and leukemia. Ann. NY Acad. Sci.1310(1), 98–110 (2014).
  • Bailly C . Contemporary challenges in the design of topoisomerase II inhibitors for cancer chemotherapy. Chem. Rev.112(7), 3611–3640 (2012).
  • Hueso-Falcón I , AmestyÁ , Anaissi-AfonsoL , Lorenzo-CastrillejoI , MachínF , Estévez-BraunA. Synthesis and biological evaluation of naphthoquinone–coumarin conjugates as topoisomerase II inhibitors. Bioorg. Med. Chem. Lett.27(3), 484–489 (2017).
  • Fransecky L , MochmannLH , BaldusCD. Outlook on PI3K/Akt/mTOR inhibition in acute leukemia. Mol. Cell. Ther.3(1), 2 (2015).
  • Wang H , JiaX-H , ChenJ-R , WangJ-Y , LiY-J. Osthole shows the potential to overcome P-glycoprotein-mediated multidrug resistance in human myelogenous leukemia K562/ADM cells by inhibiting the PI3K/Akt signaling pathway. Oncol. Rep.35, 3659–3668 (2016).
  • Zhu X , LiZ , LiTet al. Osthole inhibits the PI3K/Akt signaling pathway via activation of PTEN and induces cell cycle arrest and apoptosis in esophageal squamous cell carcinoma. Biomed. Pharmacother.102, 502–509 (2018).
  • Lu L , ShaS , WangKet al. Discovery of chromeno[4,3-c]pyrazol-4(2H)-one containing carbonyl or oxime derivatives as potential, selective inhibitors PI3Kα. Chem. Pharm. Bull. (Tokyo)64(11), 1576–1581 (2016).
  • Ma C-C , LiuZ-P. Design and synthesis of coumarin derivatives as novel PI3K inhibitors. Anticancer Agents Med. Chem.17(3), 395–403 (2017).
  • Liu H , WangY , SharmaAet al. Derivatives containing both coumarin and benzimidazole potently induce caspase-dependent apoptosis of cancer cells through inhibition of PI3K-Akt-mTOR signaling. Anticancer Drugs26(6), 667–677 (2015).
  • Hawkins PT , StephensLR. PI3K signalling in inflammation. Biochim. Biophys. Acta1851(6), 882–897 (2015).
  • Dissanayake AA , AmeenBAH , NairMG. Lipid peroxidation and cyclooxygenase enzyme inhibitory compounds from Prangos haussknechtii. J. Nat. Prod.80(9), 2472–2477 (2017).
  • Su F , ZhaoZ , MaSet al. Cnidimonins A–C, three types of hybrid dimer from Cnidium monnieri: structural elucidation and semisynthesis. Org. Lett.19(18), 4920–4923 (2017).
  • Liu B-Y , ZhangC , ZengK-Wet al. Anti-inflammatory prenylated phenylpropenols and coumarin derivatives from Murraya exotica. J. Nat. Prod.81(1), 22–33 (2018).
  • Kim NH , KimS-N , OhJS , LeeS , KimYK. Anti-mitotic potential of 7-diethylamino-3(2′-benzoxazolyl)-coumarin in 5-fluorouracil-resistant human gastric cancer cell line SNU620/5-FU. Biochem. Biophys. Res. Commun.418(4), 616–621 (2012).
  • Singh H , SinghJV , GuptaMKet al. Triazole tethered isatin-coumarin based molecular hybrids as novel antitubulin agents: design, synthesis, biological investigation and docking studies. Bioorg. Med. Chem. Lett.27(17), 3974–3979 (2017).
  • Mutai P , BreuzardG , PaganoA , AllegroD , PeyrotV , ChibaleK. Synthesis and biological evaluation of 4 arylcoumarin analogues as tubulin-targeting antitumor agents. Biorg. Med. Chem.25(5), 1652–1665 (2017).
  • Pierre C , PascaleB , EtienneDet al. The indolylcoumarin COUFIN exhibits potent activity against renal carcinoma cells without affecting hematopoietic system. Anticancer Agents Med. Chem.14(6), 862–871 (2014).
  • Cao D , LiuY , YanWet al. Design, synthesis, and evaluation of in vitro and in vivo anticancer activity of 4-substituted coumarins: a novel class of potent tubulin polymerization inhibitors. J. Med. Chem.59(12), 5721–5739 (2016).
  • Yan W , YangT , YangJet al. SKLB060 reversibly binds to colchicine site of tubulin and possesses efficacy in multidrug-resistant cell lines. Cell. Physiol. Biochem.47(2), 489–504 (2018).
  • Garazd Y , GarazdM , LesykR. Synthesis and evaluation of anticancer activity of 6-pyrazolinylcoumarin derivatives. Saudi Pharm. J.25(2), 214–223 (2017).
  • Bovell-Benjamin AC , RobertsJ. Chapter 13 – naturally occurring toxicants: presence in selected commonly consumed fruits.Regulating Safety of Traditional and Ethnic Foods.Martín-BellosoO, KeenerL, AstleyS, BraunS, McMahonH, LelieveldH ( Eds). Academic Press, CA, USA, 247–282 (2016).
  • Jacobi JL , YangB , LiXet al. Impacts on sirtuin function and bioavailability of the dietary bioactive compound dihydrocoumarin. PLoS ONE11(2), e0149207 (2016).
  • Zhang J , LiL , HaleTWet al. Single oral dose pharmacokinetics of decursin and decursinol angelate in healthy adult men and women. PLoS ONE10(2), e0114992 (2015).
  • Kim S-J , KoS-M , ChoiE-Jet al. Simultaneous determination of decursin, decursinol angelate, nodakenin, and decursinol of Angelica gigas Nakai in human plasma by UHPLC-MS/MS: application to pharmacokinetic study. Molecules23(5), 1019 (2018).
  • Wang P , XiaY-L , YuYet al. Design, synthesis and biological evaluation of esculetin derivatives as anti-tumour agents. RSC Adv.5(66), 53477–53483 (2015).
  • Xia Y-L , GeG-B , WangPet al. Structural modifications at the C-4 position strongly affect the glucuronidation of 6,7-dihydroxycoumarins. Drug Metab. Disposition43(4), 553–560 (2015).
  • Zhu L , LuL , ZengSet al. UDP-glucuronosyltransferases 1A6 and 1A9 are the major isozymes responsible for the 7-O-glucuronidation of esculetin and 4-methylesculetin in human liver microsomes. Drug Metab. Disposition43(7), 977–983 (2015).
  • Liang S-C , XiaY-L , HouJet al. Methylation, glucuronidation, and sulfonation of daphnetin in human hepatic preparations in vitro: metabolic profiling, pathway comparison, and bioactivity analysis. J. Pharm. Sci.105(2), 808–816 (2016).
  • Xia Y-L , DouT-Y , LiuY , WangP , GeG-B , YangL. In vitro evaluation of the effect of C-4 substitution on methylation of 7,8-dihydroxycoumarin: metabolic profile and catalytic kinetics. R. Soc. Open Sci.5(1), 171271 (2018).
  • Xia Y-L , LiangS-C , ZhuL-Let al. Identification and characterization of human UDP-glucuronosyltransferases responsible for the glucuronidation of fraxetin. Drug Metab. Pharmacokinet.29(2), 135–140 (2014).
  • Yang Y-F , ZhangL , ZhangY-B , YangX-W. Simultaneous assessment of absorption characteristics of coumarins from Angelicae pubescentis Radix: in vitro transport across Caco-2 cell and in vivo pharmacokinetics in rats after oral administration. J. Chromatogr. B1060, 308–315 (2017).
  • Zhang L , GeY , LiJet al. Simultaneous determination of columbianetin-β-d-glucopyranoside and columbianetin in a biological sample by high-performance liquid chromatography with fluorescence detection and identification of other columbianetin-β-d-glucopyranoside metabolites by ultra high-performance liquid chromatography coupled with quadrupole-time of flight mass spectrometry. J. Pharm. Biomed. Anal.153, 221–231 (2018).
  • Meanwell NA . The influence of bioisosteres in drug design: tactical applications to address developability problems. Tactics in Contemporary Drug Design.MeanwellNA ( Ed.). Springer Berlin Heidelberg, Berlin, Heidelberg, Germany, 283–381 (2015).
  • Nicolotti O , PisaniL , CattoMet al. Discovery of a potent and selective hetero-bivalent AChE inhibitor via bioisosteric replacement. Mol. Inform.30(2-3), 133–136 (2011).
  • Daina A , MichielinO , ZoeteV. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep.7, 42717 (2017).
  • Eriksson H , SvenssonL , TörngrenM. EP3180005 (B1) (2017).
  • Isaacs JT , DalrympleSL , RosenDM , HammersH , OlssonA , LeandersonT. Anti-cancer potency of tasquinimod is enhanced via albumin-binding facilitating increased uptake in the tumor microenvironment. Oncotarget5(18), 8093–8106 (2014).
  • Tashima T . The structural use of carbostyril in physiologically active substances. Bioorg. Med. Chem. Lett.25(17), 3415–3419 (2015).
  • Tashima T , MurataH , KodamaH. Design and synthesis of novel and highly-active pan-histone deacetylase (pan-HDAC) inhibitors. Biorg. Med. Chem.22(14), 3720–3731 (2014).
  • National Center for Biotechnology Information . Lunacridine. (2018). https://pubchem.ncbi.nlm.nih.gov/compound/442920
  • DrugBank . Tipifarnib. (2018). www.drugbank.ca/drugs/DB04960
  • Vardhan Reddy KH , BrionJ-D , MessaoudiS , AlamiM. Synthesis of biheterocycles based on quinolinone, chromone, and coumarin scaffolds by palladium-catalyzed decarboxylative couplings. J. Org. Chem.81(2), 424–432 (2016).
  • Tars K , VulloD , KazaksAet al. Sulfocoumarins (1,2-Benzoxathiine-2,2-dioxides): a class of potent and isoform-selective inhibitors of tumor-associated carbonic anhydrases. J. Med. Chem.56(1), 293–300 (2013).
  • Grandane A , TancM , ZalubovskisR , SupuranCT. 6-Triazolyl-substituted sulfocoumarins are potent, selective inhibitors of the tumor-associated carbonic anhydrases IX and XII. Bioorg. Med. Chem. Lett.24(5), 1256–1260 (2014).
  • Ferraroni M , CartaF , ScozzafavaA , SupuranCT. Thioxocoumarins show an alternative carbonic anhydrase inhibition mechanism compared to coumarins. J. Med. Chem.59(1), 462–473 (2016).
  • Lomelino C , SupuranC , McKennaR. Non-classical inhibition of carbonic anhydrase. Int. J. Mol. Sci.17(7), 1150 (2016).
  • Hyohdoh I , FuruichiN , AokiTet al. Fluorine scanning by nonselective fluorination: enhancing Raf/MEK inhibition while keeping physicochemical properties. ACS Med. Chem. Lett.4(11), 1059–1063 (2013).
  • Chenard-Poirier M , KaiserM , BoydKet al. Results from the biomarker-driven basket trial of RO5126766 (CH5127566), a potent RAF/MEK inhibitor, in RAS- or RAF-mutated malignancies including multiple myeloma. J. Clin. Oncol.35(Suppl. 15), 2506 (2017).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.